Clinical Trial Update: Ticagrelore Alone Post PCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ticagrelor alone after percutaneous coronary intervention; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Coronary Artery Disease | Phase 4 | Status: RECRUITING